The notices it replaced
- Reissues: PAR-17-274 NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (U01)
- 2 steps back: PAR-14-220 NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (U01)
Replaced by PAR-20-285.
Who won it before
13 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $56,595,760 in first-year total cost, median $3,992,880.
Most frequent study sections
- Special Emphasis Panel[ZNS1 SRB-G (33)]3
- Special Emphasis Panel[ZNS1 SRB-G (14)]2
- Special Emphasis Panel[ZNS1 SRB-H (01)]2
- Neurological Sciences and Disorders K Study Section[NSD-K]1
- Special Emphasis Panel[ZNS1 SRB-G (03)]1
Most frequent institutions
- UNIVERSITY OF CINCINNATI3
- BETH ISRAEL DEACONESS MEDICAL CENTER2
- STANFORD UNIVERSITY2
- COLUMBIA UNIVERSITY HEALTH SCIENCES1
- MEDICAL UNIVERSITY OF SOUTH CAROLINA1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2021 | Comparison of Anti-coagulation and anti-Platelet Therapies for Intracranial Vascular Atherostenosis1U01NS117450-01A1 | CHIMOWITZ, MARC IVORHOH, BRIAN LIM | UNIVERSITY OF FLORIDA, FL | $8,624,024 | ZNS1 |
| 2021 | Validation of Early Prognostic Data for Recovery Outcomes after Stroke for Future, Higher Yield Trials (VERIFY)1U01NS120910-01 | CRAMER, STEVEN C.KHATRI, POOJASTINEAR, CATHYVAGAL, ACHALA SAMEER | UNIVERSITY OF CINCINNATI, OH | $3,992,880 | ZNS1 |
| 2021 | StAtins Use in intRacereberal hemorrhage patieNts MRI (SATURN MRI) Ancillary Study1UF1NS120871-01 | SELIM, MAGDY HSHOAMANESH, ASHKAN | BETH ISRAEL DEACONESS MEDICAL CENTER, MA | $2,705,364 | ZNS1 |
| 2020 | FVIIa for Acute hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial1U01NS110772-01 | BRODERICK, JOSEPH PAULELM, JORDAN J.GROTTA, JAMES CNAIDECH, ANDREW M | UNIVERSITY OF CINCINNATI, OH | $6,472,265 | ZNS1 |
| 2019 | Anticoagulation in ICH Survivors for Prevention and Recovery (ASPIRE)1U01NS106513-01A1 | KAMEL, HOOMANSHETH, KEVIN NAVIN | YALE UNIVERSITY, CT | $4,032,209 | ZNS1 |
| 2019 | StATins Use in intRacerebral hemorrhage patieNts (SATURN)1U01NS102289-01A1 · under PAR-17-274 | SELIM, MAGDY H | BETH ISRAEL DEACONESS MEDICAL CENTER, MA | $3,014,650 | ZNS1 |
| 2019 | Perinatal Arterial Stroke: A Multi-site RCT of Intensive Infant Rehabilitation (I-ACQUIRE)1U01NS106655-01A1 | LO, WARREN DAVIDRAMEY, SHARON LANDESMAN | VIRGINIA POLYTECHNIC INST AND ST UNIV, VA | $2,926,648 | ZNS1 |
| 2019 | ARCADIA CSI (Cognition and Silent Infarcts)1U01NS110728-01 | LANSBERG, MAARTEN GLAZAR, RONALD M | STANFORD UNIVERSITY, CA | $1,922,432 | ZNS1 |
| 2018 | Sleep for Stroke Management And Recovery Trial (Sleep SMART)1U01NS099043-01A1 · under PAR-14-220 | BROWN, DEVIN LCHERVIN, RONALD D | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $7,487,394 | ZNS1 |
| 2018 | Multi-arm Optimization of Stroke Thrombolysis (MOST) Stroke Trial1U01NS100699-01A1 · under PAR-14-220 | ADEOYE, OPEOLU MBARRETO, ANDREW DBRODERICK, JOSEPH PAULGROTTA, JAMES C | UNIVERSITY OF CINCINNATI, OH | $5,966,429 | ZNS1 |
| 2018 | TRANScranial direct current stimulation for POst-stroke motor Recover - a phase II sTudy (TRANSPORT 2)1U01NS102353-01A1 · under PAR-17-274 | FENG, WUWEISCHLAUG, GOTTFRIED | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $2,445,380 | ZNS1 |
| 2017 | AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenicstroke (ARCADIA)1U01NS095869-01A1 · under PAR-14-220 | BRODERICK, JOSEPH PAULELKIND, MITCHELL SKAMEL, HOOMANLONGSTRETH, WTMEINZER, CAITLYN NTIRSCHWELL, DAVID L | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $4,072,827 | NSD |
| 2015 | DEFUSE 3: EnDovascular ThErapy Following Imaging EvalUation for ISchemic StrokE 31U01NS092076-01A1 · under PAR-14-220 | ALBERS, GREGORY W | STANFORD UNIVERSITY, CA | $2,933,258 | ZNS1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.